Decoy Therapeutics, Inc. (DCOY), a preclinical biopharmaceutical company, announced on Tuesday that the development of its peptide-conjugate antiviral platform has reached a Global Access Commitment Agreement (GACA) with the Gates Foundation to support making countermeasures for emerging pathogens, reachable to people in low- and middle-income countries.
Following the announcement, DCOY shares are surging 48% to $1.23.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.